Search

Rockeby to acquire bird flu rapid tests globally

West Perth-based biotechnology company Rockeby Biomed Ltd has signed a Memorandum of Understanding with Pacific Biotech, whereby Pacific will assign the ownership of the avian and human influenza rapid diagnostic tests to Rockeby .

The company said the change from the previous marketing agreement to a full rights agreement would result in a reduction in the direct cost of both products of approximately 70 per cent.

Rockeby said the reduction would give the company a competitive edge in the market, and improve the long-term financial return to Rockeby.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

Sign up here for free access to 7 articles per month + twice daily business email alerts.

CAPTCHA
Thanks! This question prevents spammers...
Image CAPTCHA
Enter the characters shown in the image.

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 28/04/17

1 year TSR5 year TSR
163rdSouth3271%0%
176thFortescue Metals Group65%2%
340thWoodside Petroleum18%4%
358thNorthern Star Resources13%42%
645thAtlas Iron-30%-64%
707 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

20/04/17
$52k Bought
03/11/16
$6.9m Bought
23/09/16
$0 Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

1st-Fortescue Metals Group$9,806.1m
2nd↑South32$8,262.9m
3rd-Woodside Petroleum$5,715.9m
4th↑Atlas Iron$803.7m
5th-Northern Star Resources$787.2m
494 listed resources companies ranked by revenue.
Source: Morningstar

Remuneration from Fortescue Metals Group

4thNev Power$5.324m
700thMark Barnaba$223k
829thSharon Warburton$170k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer